OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert Novo.../  DE000ME8HRW5  /

Stuttgart
13/05/2024  18:04:13 Chg.+2.17 Bid22:00:33 Ask22:00:33 Underlying Strike price Expiration date Option type
109.40EUR +2.02% -
Bid Size: -		 -
Ask Size: -		 - - DKK 31/12/2024 Call
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 07/05 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
TeleTrader 25/04 Europe opens mostly down after corporate earnings
GlobeNewswire 22/04 Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...
GlobeNewswire 22/04 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 22/04 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 11/04 Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
GlobeNewswire 02/04 Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting C...
GlobeNewswire 02/04 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 28/03 Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategi...
GlobeNewswire 27/03 Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completio...
GlobeNewswire 25/03 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...
GlobeNewswire 18/03 Arch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ ...
GlobeNewswire 15/03 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire 15/03 University of Calgary Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated...
GlobeNewswire 12/03 Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program...
GlobeNewswire 12/03 ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOA...
GlobeNewswire 11/03 FUJIFILM Diosynth Biotechnologies Appoints Richard McAvoy as Chief Financial Officer
GlobeNewswire 07/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. -...
GlobeNewswire 07/03 Arch Biopartners Announces Dosing of First Patient in Phase II Trial for LSALT Peptide Targeting Car...
GlobeNewswire 01/03 SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of...
GlobeNewswire 28/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. -...
GlobeNewswire 28/02 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Cla...
TeleTrader 26/02 Zealand Pharma soars 30% on positive weight-loss drug results
GlobeNewswire 24/02 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Sec...